Michael V Muench
Physician at Susan Ln, Point Pleasant Beach, NJ
License number
Colorado 46548
Issued Date
Apr 14, 2008
Renew Date
May 1, 2015
Expiration Date
Apr 30, 2017
Type
Physician
Address
Address
1405 Susan Ln, Point Pleasant Beach, NJ 08742
Professional information
Nutritional Supplement For Pregnant Females
US Patent:
2007023, Oct 4, 2007
Filed:
Oct 23, 2006
Appl. No.:
11/552015
Inventors:
Michael V. Muench - Point Pleasant NJ, US
Lori L. Muench - Point Pleasant NJ, US
Steven M. Feld - Loch Arbour (Allenhurst) NJ, US
Lori L. Muench - Point Pleasant NJ, US
Steven M. Feld - Loch Arbour (Allenhurst) NJ, US
International Classification:
A61K 38/43, A61K 31/714, A61K 31/675, A61K 31/525, A61K 31/4415, A61K 31/405, A61K 31/375, A61K 31/415, A61K 31/198, A61K 31/192, A61K 31/616
US Classification:
424 941, 424702, 424643, 514 52, 514165, 514251, 514 89, 514350, 514458, 514763, 514562, 514474, 514419, 514406, 514570
Abstract:
Preeclampsia and intrauterine growth restriction in a pregnant female mammal are prevented or decreased in severity by administering thereto a combination of a vitamin compound containing B1, Folic Acid (or active form 5-Methyl-Tetrahydrofolate i.e.; Metafolin®), B 6 (Pyridoxine or active form Pyridoxine 5-Phosphate P5P), B 12, Ascorbic Acid, Selenium, Zinc, Co-enzyme Q 10 and N-Acytyl Cysteine, Lycopene, optionally in further combination with Melatonin and/or Vitamin E or/and ASA 81 mg both of later, are cyclooxygenase inhibitors, a PGI.sub.2-mimetic, a thromboxane (TXA.sub.2) inhibitor, a compound possessing TXA.sub.2-agonistic and TXA.sub.2-inhibiting properties, a compound possessing TXA.sub.2-antagonistic and PGI.sub.2-mimetic activities, and a TXA.sub.2 antagonist.